Johann Gout

10PUBLICATIONS
56CO-AUTHORS
Tissue engineeringMolecular targetsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 28, 2025
DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic Cancer.

Dharini Srinivasan, Elodie Roger, Lukas Perkhofer

|Aug 18, 2025
Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy.

Alica K Beutel, Christopher J Halbrook, Menar Ekizce

|Nov 14, 2024
Organoid-based precision medicine in pancreatic cancer.

Alica K Beutel, Menar Ekizce, Thomas J Ettrich

|Mar 21, 2023
TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration.

Michael Karl Melzer, Silvia Schirge, Johann Gout

|Feb 03, 2022
Organoids at the PUB: The Porcine Urinary Bladder Serves as a Pancreatic Niche for Advanced Cancer Modeling.

Michael Karl Melzer, Markus Breunig, Frank Arnold

Pageof 2